Upgrade to FINVIZ*Elite to get real-time quotes, intraday charts, and advanced charting tools.

NEW: Price Reaction to Earnings Reports

View detailed tables showing price action before and after earnings announcements, ranging from intraday to one week out. Track how the market has reacted to past earnings to identify patterns and predict future behavior. Click here to open.

CLPT

ClearPoint Neuro Inc

Dec 13 • 04:00PM ET

15.32

Dollar change -1.07
Percentage change -6.55	%

Healthcare • Medical Devices • USA • NASD

Peers: AXNX NVCR NNOX NURO ARVN STXS PAVM LAKE LCTX BCLI

| Held by: VTI VXF IWC QQQS IBRN BTEC RFLR

Scroll to Statements

Index	-	P/E	-	EPS (ttm)	-0.69	Insider Own	13.36%	Shs Outstand	27.59M	Perf Week	13.69%
Market Cap	395.03M	Forward P/E	-	EPS next Y	-0.58	Insider Trans	0.00%	Shs Float	23.90M	Perf Month	39.95%
Income	-18.15M	PEG	-	EPS next Q	-0.16	Inst Own	25.13%	Short Float	3.08%	Perf Quarter	23.59%
Sales	30.43M	P/S	12.98	EPS this Y	25.33%	Inst Trans	-0.09%	Short Ratio	3.22	Perf Half Y	183.27%
Book/sh	1.05	P/B	14.58	EPS next Y	13.11%	ROA	-43.19%	Short Interest	0.74M	Perf Year	133.97%
Cash/sh	0.84	P/C	18.31	EPS next 5Y	30.00%	ROE	-68.36%	52W Range	5.11 - 17.47	Perf YTD	125.70%
Dividend Est.	-	P/FCF	-	EPS past 5Y	-9.74%	ROI	-56.43%	52W High	-12.28%	Beta	1.06
Dividend TTM	-	Quick Ratio	3.61	Sales past 5Y	27.32%	Gross Margin	60.38%	52W Low	200.20%	ATR (14)	0.95
Dividend Ex-Date	-	Current Ratio	4.54	EPS Y/Y TTM	22.25%	Oper. Margin	-61.94%	RSI (14)	65.37	Volatility	10.00% 6.70%
Employees	107	Debt/Eq	0.13	Sales Y/Y TTM	36.34%	Profit Margin	-59.64%	Recom	1.00	Target Price	16.33
Option/Short	Yes / Yes	LT Debt/Eq	0.11	EPS Q/Q	7.63%	Payout	-	Rel Volume	1.14	Prev Close	16.40
Sales Surprise	4.57%	EPS Surprise	-3.87%	Sales Q/Q	40.96%	Earnings	Nov 07 AMC	Avg Volume	228.91K	Price	15.32
SMA20	19.17%	SMA50	22.63%	SMA200	73.38%	Trades		Volume	259,962	Change	-6.55%

Date	Action	Analyst	Rating Change	Price Target Change
Jul-25-24	Resumed	B. Riley Securities	Buy	$10
Oct-24-23	Initiated	Stifel	Buy	$8
Feb-16-23	Resumed	B. Riley Securities	Buy	$14
Apr-05-22	Resumed	B. Riley Securities	Buy	$15
Mar-18-21	Initiated	Lake Street	Buy	$32
Jul-17-20	Initiated	B. Riley FBR	Buy	$8

Nov-13-24 06:15PM	ClearPoint Neuro Announces FDA De Novo Marketing Authorization of SmartFlow Cannula for Direct Delivery of Gene Therapy to the Brain (ACCESSWIRE)
Nov-07-24 04:05PM	ClearPoint Neuro Reports Third Quarter 2024 Results (ACCESSWIRE) -13.19%
Nov-06-24 07:38AM	ClearPoint Neuro Inc (CLPT) Q3 2024 Earnings Report Preview: What To Expect (GuruFocus.com)
Oct-31-24 04:05PM	ClearPoint Neuro to Participate in Multiple Global Healthcare Conferences in the Fourth Quarter of 2024 (ACCESSWIRE)
Oct-17-24 04:05PM	ClearPoint Neuro to Announce Third Quarter 2024 Results November 7, 2024 (GlobeNewswire) +11.61%
04:05PM	Loading…
Aug-26-24 04:05PM	ClearPoint Neuro Announces Early Repayment of $10 Million Note (GlobeNewswire) +8.97%
Aug-07-24 04:05PM	ClearPoint Neuro Reports Second Quarter 2024 Results (GlobeNewswire) +40.68%
Jul-17-24 04:05PM	ClearPoint Neuro to Announce Second Quarter 2024 Results August 7, 2024 (GlobeNewswire)
Jul-10-24 03:51AM	Strength Seen in ClearPoint Neuro (CLPT): Can Its 16.9% Jump Turn into More Strength? (Zacks) +9.88%
Jun-20-24 08:45AM	ClearPoint Neuro Congratulates Partner Aspen Neuroscience on Use of the ClearPoint Navigation System for All Enrolled Patients in ASPIRO Clinical Trial (GlobeNewswire) +5.52%
08:30AM	Parkinson's Disease Clinical Trial Uses Intraoperative MRI to Guide Precision Implantation of Patients' Own Autologous Replacement Neurons (PR Newswire)
Jun-03-24 11:53AM	ClearPoint's (CLPT) New Products to Boost Neurosurgical Segment (Zacks)
Jun-01-24 09:00AM	ClearPoint Neuro Announces Full Market Release of SmartFrame OR and ClearPoint PRISM 3T Laser Therapy System (GlobeNewswire)
May-29-24 09:55AM	Does ClearPoint Neuro (CLPT) Have the Potential to Rally 81.49% as Wall Street Analysts Expect? (Zacks)
May-13-24 09:55AM	Wall Street Analysts Predict a 70.65% Upside in ClearPoint Neuro (CLPT): Here's What You Should Know (Zacks)
03:53AM	Loading…
May-08-24 03:53AM	ClearPoint Neuro Inc (CLPT) Q1 2024 Earnings Call Transcript Highlights: Robust Revenue Growth ... (GuruFocus.com)
May-07-24 08:58PM	CLPT Stock Earnings: ClearPoint Neuro Beats EPS, Beats Revenue for Q1 2024 (InvestorPlace)
04:05PM	ClearPoint Neuro Reports First Quarter 2024 Results (GlobeNewswire)
May-02-24 04:05PM	ClearPoint Neuro to Present Novel Research and Exhibit at the 27th American Society of Gene & Cell Therapy Annual Meeting in Baltimore (GlobeNewswire) +6.34%
May-01-24 04:30PM	7 Penny Stocks That Could Make You a Fortune (If You Dare) (InvestorPlace)
Apr-29-24 08:00AM	ClearPoint Neuro Announces FDA Clearance of Prism Bone Anchor Accessory (GlobeNewswire)
Apr-24-24 04:05PM	ClearPoint Neuro Announces Initiation of Limited Market Release for the SmartFrame OR Stereotactic System (GlobeNewswire)
Apr-23-24 04:05PM	ClearPoint Neuro to Announce First Quarter 2024 Results May 7, 2024 (GlobeNewswire)
Apr-16-24 04:05PM	ClearPoint Neuro Congratulates its Partner AviadoBio on First Patient Treated in its ASPIRE-FTD Clinical Trial Evaluating AVB-101 for Frontotemporal Dementia with GRN Mutations (GlobeNewswire)
Mar-27-24 08:32AM	Why ClearPoint Neuro (CLPT) Stock Might be a Great Pick (Zacks)
Mar-19-24 08:07AM	ClearPoint Neuro Congratulates its Partner PTC Therapeutics on Completion of Biologics License Application Submission to FDA for Upstaza as a Treatment for AADC Deficiency (GlobeNewswire)
Mar-16-24 03:39PM	ClearPoint Neuro, Inc. (NASDAQ:CLPT) Q4 2023 Earnings Call Transcript (Insider Monkey)
Mar-12-24 05:40PM	ClearPoint Neuro, Inc. (CLPT) Reports Q4 Loss, Tops Revenue Estimates (Zacks) +18.51%
05:39PM	ClearPoint Neuro Inc Reports Robust Revenue Growth in Q4 and Full-Year 2023 (GuruFocus.com)
04:05PM	ClearPoint Neuro Reports Fourth Quarter and Full-Year 2023 Results (GlobeNewswire)
10:36AM	Loading…
10:36AM	ClearPoint's (CLPT) Prism System Favored by Latest Study (Zacks)
Mar-11-24 08:00AM	Journal of Neurosurgery Publication Demonstrates Distinct Advantages of ClearPoint Prism Neuro Laser Therapy System (GlobeNewswire)
Mar-01-24 04:05PM	ClearPoint Neuro to Announce Fourth Quarter and Full Year 2023 Results March 12, 2024 (GlobeNewswire)
Feb-29-24 08:00AM	ClearPoint Neuro Announces Pricing of Public Offering of 2,307,694 Shares of Common Stock (GlobeNewswire) -17.23%
Feb-28-24 04:45PM	ClearPoint Neuro Launches Proposed Public Offering of Common Stock (GlobeNewswire)
Feb-26-24 11:01AM	ClearPoint Neuro (CLPT) Gets FDA's Nod for New Software (Zacks)
Feb-21-24 04:05PM	ClearPoint Neuro Announces FDA Clearance and First-in-Human Cases Performed with the New 2.2 Software Version and the Integrated Maestro Brain Model (GlobeNewswire)
Jan-24-24 04:05PM	ClearPoint Neuro Announces Installation and First Procedure Using the ClearPoint Prism Neuro Laser Therapy System and Navigation System at Kaleida Health in Buffalo (GlobeNewswire) -7.39%
Jan-22-24 04:05PM	ClearPoint Neuro Announces First EU MDR Certification Success and Approval to Ship Product to Europe (GlobeNewswire)
Jan-17-24 10:38AM	ClearPoint Neuro (CLPT) Gets FDA's Nod for SmartFrame OR System (Zacks)
Jan-16-24 08:00AM	ClearPoint Neuro Announces FDA Clearance for SmartFrame OR Stereotactic System (GlobeNewswire) +5.30%
Jan-08-24 04:05PM	ClearPoint Neuro Reports Fourth Quarter and Full Year 2023 Preliminary Revenue Results and Guidance for Full Year 2024 Revenue (GlobeNewswire) +17.91%
Nov-10-23 02:38PM	ClearPoint Neuro, Inc. (NASDAQ:CLPT) Q3 2023 Earnings Call Transcript (Insider Monkey) -17.71%
Nov-09-23 04:05PM	ClearPoint Neuro Reports Third Quarter 2023 Results (GlobeNewswire) -7.82%
Oct-26-23 04:05PM	ClearPoint Neuro to Announce Third Quarter 2023 Results November 9, 2023 (GlobeNewswire) -6.02%
Aug-08-23 04:05PM	ClearPoint Neuro Reports Second Quarter 2023 Results (GlobeNewswire)
Jul-25-23 04:05PM	ClearPoint Neuro to Announce Second Quarter 2023 Results August 8, 2023 (GlobeNewswire)
May-24-23 09:25AM	ClearPoint Neuro and UCB Enter License Agreement for Gene Therapy Drug Delivery (GlobeNewswire)
May-18-23 04:01PM	ClearPoint Neuro to Present at the B. Riley Securities 2023 Institutional Investor Conference (GlobeNewswire)
May-11-23 04:05PM	ClearPoint Neuro Reports First Quarter 2023 Results (GlobeNewswire) -5.41%
May-10-23 04:05PM	ClearPoint Neuro to Present Investigational Research and Showcase Novel Innovations at the 26th American Society of Gene & Cell Therapy Annual Meeting in Los Angeles (GlobeNewswire)
Apr-28-23 04:42PM	ClearPoint Neuro to Announce First Quarter 2023 Results May 11, 2023 (GlobeNewswire)
Apr-20-23 04:05PM	ClearPoint Neuro to Showcase Two Novel Innovations at AANS 2023: ClearPoint Maestro® Brain Model and ClearPoint Prism Neuro Laser Therapy System (GlobeNewswire)
Apr-18-23 04:05PM	ClearPoint Neuro Announces Agreement with NE Scientific to Integrate Gene Therapy Infusion Coverage Tool into ClearPoint Maestro® Brain Model (GlobeNewswire)
12:33PM	Market Participants Recognise ClearPoint Neuro, Inc.'s (NASDAQ:CLPT) Revenues Pushing Shares 37% Higher (Simply Wall St.)
Apr-13-23 04:05PM	ClearPoint Neuro Announces ANVISA Approval of Neuro Navigation Portfolio in Brazil (GlobeNewswire) +11.01%
Apr-11-23 04:05PM	ClearPoint Neuro Extends Software License and Research Agreement with Philips to Include Fully Automatic Subnuclei Segmentation for DBS (GlobeNewswire)
Mar-28-23 04:05PM	ClearPoint Neuro Announces Exclusive Multi-Year Licensing Agreement with UCSF for Innovative Intra-Cerebral Cellular Delivery Platform (GlobeNewswire) +6.29%
Mar-01-23 04:05PM	ClearPoint Neuro Reports Fourth Quarter and Full-Year 2022 Results (GlobeNewswire) +7.19% -9.79%
Feb-15-23 04:05PM	ClearPoint Neuro to Announce Fourth Quarter and Full Year 2022 Revenue Results March 1, 2023 (GlobeNewswire)
Jan-11-23 08:00AM	ClearPoint Neuro Reports Fourth Quarter and Full Year 2022 Preliminary Revenue Results and Guidance for Full Year 2023 Revenue (GlobeNewswire)
Dec-12-22 09:15AM	ClearPoint Neuro Announces First Patient Enrolled in Glioblastoma Trial Using ClearPoint Prism Neuro Laser Therapy System at Skåne University Hospital in Sweden (GlobeNewswire)
Nov-09-22 09:25AM	ClearPoint Neuro to Present at Upcoming Investor Conferences (GlobeNewswire) -5.37%
Nov-08-22 04:05PM	ClearPoint Neuro Reports Third Quarter 2022 Results (GlobeNewswire)
Oct-26-22 04:05PM	ClearPoint Neuro to Announce Third Quarter 2022 Results November 8, 2022 (GlobeNewswire)
Sep-23-22 02:45AM	ClearPoint Neuro Announces FDA Clearance for ClearPoint Prism Neuro Laser Therapy System (GlobeNewswire) +5.04%
Sep-20-22 04:05PM	ClearPoint Neuro Announces Appointment of Mazin Sabra as Chief Operating Officer (GlobeNewswire) -5.27%
Sep-19-22 04:13PM	ClearPoint Neuro Announces FDA Clearance for Software Version 2.1 (GlobeNewswire)
Aug-09-22 04:15PM	ClearPoint Neuro Reports Second Quarter 2022 Results (GlobeNewswire) +13.57%
04:05PM	ClearPoint Neuro Announces FDA Clearance for ClearPoint Maestro Brain Model (GlobeNewswire)
Aug-08-22 04:05PM	ClearPoint Neuro, Inc. Announces Appointment of Mary McNamara-Cullinane as Vice President of Regulatory Affairs (GlobeNewswire)
Jul-26-22 04:05PM	ClearPoint Neuro to Announce Second Quarter 2022 Results August 9, 2022 (GlobeNewswire) +5.47%
Jul-21-22 04:20PM	ClearPoint Neuro Congratulates Partner PTC Therapeutics on Being Granted Marketing Authorization by the European Commission for Upstaza - First Disease-Modifying Treatment for AADC Deficiency (GlobeNewswire) -7.81%
Jun-29-22 04:05PM	ClearPoint Neuro Congratulates Neurona Therapeutics on Dosing of Initial Subject in First Clinical Trial of Regenerative Human Cell Therapy in Adults with Drug-Resistant Focal Epilepsy (GlobeNewswire)
Jun-02-22 04:05PM	ClearPoint Neuro Announces Receipt of MDSAP Certification (GlobeNewswire) +5.85%
May-20-22 09:29AM	ClearPoint Neuro Congratulates Partner PTC Therapeutics on Receiving Positive CHMP Opinion for Gene Therapy to Treat AADC Deficiency (GlobeNewswire) +13.59%
May-13-22 09:25AM	ClearPoint Neuro to Present Investigational Research and Exhibit at the American Society of Gene & Cell Therapy Annual Meeting in Washington, DC (GlobeNewswire) +10.47%
May-11-22 04:05PM	ClearPoint Neuro Reports First Quarter 2022 Results (GlobeNewswire) -7.44% +9.17%
May-06-22 02:13PM	Investing in ClearPoint Neuro (NASDAQ:CLPT) three years ago would have delivered you a 179% gain (Simply Wall St.) -7.97%
May-03-22 04:05PM	ClearPoint Neuro and Higgs Boson Health Announce Collaboration (GlobeNewswire) +5.58%
Apr-28-22 04:05PM	ClearPoint Neuro Announces FDA Clearance of the SmartFrame Array Version 1.1 (GlobeNewswire)
Apr-27-22 04:05PM	ClearPoint Neuro Expands Software License and Research Agreement with Philips to Power Expansion of the ClearPoint Platform into the Operating Room (GlobeNewswire)
Apr-26-22 04:05PM	ClearPoint Neuro to Announce First Quarter 2022 Results May 11, 2022 (GlobeNewswire) -7.45%
Mar-29-22 04:01PM	ClearPoint Neuro to Present at the B. Riley Securities Disruptive Biotech Enabling Technologies Mini Conference (GlobeNewswire) +9.18%
Mar-21-22 08:17PM	Is ClearPoint Neuro (NASDAQ:CLPT) Weighed On By Its Debt Load? (Simply Wall St.)
Mar-01-22 04:07PM	ClearPoint Neuro Reports Fourth Quarter and Full-Year 2021 Results (GlobeNewswire)
Feb-15-22 04:05PM	ClearPoint Neuro Reports Fourth Quarter and Full Year 2021 Preliminary Revenue Results and Guidance for Full Year 2022 Revenue (GlobeNewswire)
Jan-13-22 01:38PM	Adirondack Trust Co Buys Vanguard Russell 2000 Index Fund, Ford Motor Co, Arco Platform, Sells ... (GuruFocus.com)
Jan-05-22 04:05PM	ClearPoint Neuro to Participate at the H.C. Wainwright BIOCONNECT Virtual Conference (GlobeNewswire) -5.63%
Dec-17-21 04:38AM	Royce Value Trust, Inc. Buys Calix Inc, MaxCyte Inc, Dutch Bros Inc, Sells EQT Corp, ... (GuruFocus.com)
Nov-20-21 07:01AM	ClearPoint Neuro (NASDAQ:CLPT) shareholders are still up 635% over 3 years despite pulling back 13% in the past week (Simply Wall St.)
Nov-17-21 04:05PM	ClearPoint Neuro Congratulates Blackrock Neurotech on Receiving Breakthrough Device Designation from the FDA for the MoveAgain Brain-Computer Interface System (GlobeNewswire)
Nov-09-21 04:05PM	ClearPoint Neuro Reports Third Quarter 2021 Results (GlobeNewswire) -6.86%
Nov-08-21 04:05PM	ClearPoint Neuro Congratulates Neurona Therapeutics on IND Clearance for Neural Cell Therapy NRTX-1001 in Chronic Focal Epilepsy Patients (GlobeNewswire)
Nov-04-21 04:05PM	ClearPoint Neuro to Present at the 2021 Stifel Virtual Healthcare Conference (GlobeNewswire)
Nov-02-21 04:05PM	Internationally Renowned Neurosurgeon and Accomplished Researcher Dr. Linda M. Liau Joins ClearPoint Neuro Board of Directors (GlobeNewswire)
Oct-26-21 04:05PM	ClearPoint Neuro to Announce Third Quarter 2021 Results November 9, 2021 (GlobeNewswire)
Sep-21-21 07:19AM	Is ClearPoint Neuro (NASDAQ:CLPT) Weighed On By Its Debt Load? (Simply Wall St.)
Aug-10-21 04:05PM	ClearPoint Neuro Reports Second Quarter 2021 Results (GlobeNewswire) -16.58%
Aug-09-21 08:00AM	ClearPoint Neuro, Inc. Announces Strategic and Commercial Partnership with European Surgical Equipment Leader adeor medical AG (GlobeNewswire)

Clearpoint Neuro, Inc. engages in the development and commercialization of platforms for performing minimally invasive surgical procedures in the brain and heart. The firm conducts its procedures under direct, intra-procedural magnetic resonance imaging guidance. Its product platform consists of the ClearPoint system and ClearTrace system. The company was founded by Paul A. Bottomley on March 12, 1998 and is headquartered in Solana Beach, CA.

Insider Trading	Relationship	Date	Transaction	#Shares	#Shares Total	SEC Form 4
SABRA MAZIN	Chief Operating Officer	Mar 06 '24	Option Exercise	6,913	47,352	Mar 08 04:41 PM
STIGALL L. JEREMY	Chief Business Officer	Mar 06 '24	Option Exercise	8,889	50,874	Mar 08 04:40 PM
D'Alessandro Danilo	Chief Financial Officer	Mar 06 '24	Option Exercise	9,383	58,312	Mar 08 04:40 PM
BURNETT JOSEPH MICHAEL	CEO and President	Mar 06 '24	Option Exercise	23,704	274,430	Mar 08 04:39 PM

open in yahoo | open in reuters | open in marketwatch | open in google | open in EDGAR

CLPT

ClearPoint Neuro Inc

Upgrade your FINVIZ experience